Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Preetesh Jain

Showing results (121-130 of 176) with videos related to

Pageof 18
Sort By:
Blood|September 15, 2020
Long-term follow-up of lenalidomide and rituximab as initial treatment of follicular lymphomaPaolo Strati, Preetesh Jain, Ralph J Johnson, et al.
Cancer|December 22, 2017
Prediction for sustained deep molecular response of BCR-ABL1 levels in patients with chronic myeloid leukemia in chronic phaseKoji Sasaki, Hagop Kantarjian, Susan O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation FailureUri Rozovski, Ohad Benjamini, Preetesh Jain, et al.
Cell Death & Disease|November 3, 2023
Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteinsYijing Li, Heng-Huan Lee, Vivian Changying Jiang, et al.
Blood Advances|July 11, 2019
Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphomaMatthew S Ning, Chelsea C Pinnix, Bhavana V Chapman, et al.
American Journal of Hematology|November 5, 2014
Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory acute lymphoblastic leukemiaTapan M Kadia, Hagop M Kantarjian, Deborah A Thomas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2022
STAT3 Activates the Pentraxin 3 Gene in Chronic Lymphocytic Leukemia CellsUri Rozovski, Ivo Veletic, David M Harris, et al.
Leukemia & Lymphoma|January 22, 2024
Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvementAnath C Lionel, Ashwath Gurumurthi, Ahmed Fetooh, et al.
Leukemia & Lymphoma|July 7, 2020
Impact of maintenance rituximab in patients with <i>de novo</i> transformed indolent B cell lymphomaCollin K Chin, Maria A Rodriguez, Yun Qing, et al.
Human Pathology|February 1, 2024
Optical genomic mapping is a helpful tool for detecting CCND1 rearrangements in CD5-negative small B-cell lymphoma: Two cases of leukemic non-nodal mantle cell lymphomaAndres E Quesada, Shimin Hu, Shaoying Li, et al.
Pageof 18

Showing results (121-130 of 176) with videos related to

Sort By:
Pageof 18
Blood|September 15, 2020
Long-term follow-up of lenalidomide and rituximab as initial treatment of follicular lymphomaPaolo Strati, Preetesh Jain, Ralph J Johnson, et al.
Cancer|December 22, 2017
Prediction for sustained deep molecular response of BCR-ABL1 levels in patients with chronic myeloid leukemia in chronic phaseKoji Sasaki, Hagop Kantarjian, Susan O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation FailureUri Rozovski, Ohad Benjamini, Preetesh Jain, et al.
Cell Death & Disease|November 3, 2023
Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteinsYijing Li, Heng-Huan Lee, Vivian Changying Jiang, et al.
Blood Advances|July 11, 2019
Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphomaMatthew S Ning, Chelsea C Pinnix, Bhavana V Chapman, et al.
American Journal of Hematology|November 5, 2014
Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory acute lymphoblastic leukemiaTapan M Kadia, Hagop M Kantarjian, Deborah A Thomas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2022
STAT3 Activates the Pentraxin 3 Gene in Chronic Lymphocytic Leukemia CellsUri Rozovski, Ivo Veletic, David M Harris, et al.
Leukemia & Lymphoma|January 22, 2024
Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvementAnath C Lionel, Ashwath Gurumurthi, Ahmed Fetooh, et al.
Leukemia & Lymphoma|July 7, 2020
Impact of maintenance rituximab in patients with <i>de novo</i> transformed indolent B cell lymphomaCollin K Chin, Maria A Rodriguez, Yun Qing, et al.
Human Pathology|February 1, 2024
Optical genomic mapping is a helpful tool for detecting CCND1 rearrangements in CD5-negative small B-cell lymphoma: Two cases of leukemic non-nodal mantle cell lymphomaAndres E Quesada, Shimin Hu, Shaoying Li, et al.
Pageof 18